(S1 (S (S (NP (NN Interleukin-1) (NN receptor) (NN antagonist)) (VP (VBZ inhibits) (NP (ADJP (ADJP (JJ ischaemic)) (CC and) (ADJP (JJ excitotoxic))) (JJ neuronal) (NN damage)) (PP (IN in) (NP (DT the) (NN rat))))) (. .)))
(S1 (S (S (S (NP (NP (NP (NP (NN Interleukin-1)) (PRN (-LRB- -LRB-) (NP (NN IL-1)) (-RRB- -RRB-))) (NN synthesis)) (PP (IN in) (NP (DT the) (NN brain)))) (VP (VBZ is) (VP (VBN stimulated) (PP (IN by) (NP (JJ mechanical) (NN injury)))))) (CC and) (S (NP (NN IL-1)) (VP (VBZ mimics) (NP (NP (DT some) (NNS effects)) (PP (IN of) (NP (NN injury))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN gliosis)) (CC and) (NP (NN neovascularization)))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (JJ neuronal) (NN death)) (VP (VBG resulting) (PP (IN from) (NP (NP (JJ focal) (JJ cerebral) (NN ischaemia)) (PRN (-LRB- -LRB-) (NP (NP (JJ middle) (JJ cerebral) (NN artery) (NN occlusion)) (, ,) (NP (CD 24) (NN h))) (-RRB- -RRB-)))))) (VP (VBZ is) (ADVP (RB significantly)) (VP (VBN inhibited) (PRN (-LRB- -LRB-) (PP (IN by) (NP (CD 50) (NN %))) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN injected) (PP (IN with) (NP (NP (DT a) (JJ recombinant) (NN IL-1) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NP (NN IL-1ra)) (, ,) (NP (CD 10) (NNS micrograms)) (, ,) (NP (NP (NN icv) (CD 30) (NN min)) (PP (IN before) (NP (NP (CC and) (CD 10) (NN min)) (PP (IN after) (NP (NN ischaemia))))))) (-RRB- -RRB-))))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Excitotoxic) (NN damage)) (PP (IN due) (TO to) (NP (NP (JJ striatal) (NN infusion)) (PP (IN of) (NP (NP (DT an) (JJ NMDA-receptor) (NN agonist)) (PRN (-LRB- -LRB-) (NP (NN cis-2,4-methanoglutamate)) (-RRB- -RRB-))))))) (VP (VBD was) (ADVP (RB also)) (ADVP (RB markedly)) (VP (VBN inhibited) (PRN (-LRB- -LRB-) (NP (CD 71) (NN %)) (-RRB- -RRB-)) (PP (IN by) (NP (NP (NN injection)) (PP (IN of) (NP (DT the) (NN IL-1ra)))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (JJ endogenous) (NN IL-1)) (VP (VBZ is) (NP (NP (DT a) (NN mediator)) (PP (IN of) (NP (ADJP (ADJP (JJ ischaemic)) (CC and) (ADJP (JJ excitotoxic))) (NN brain) (NN damage))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN IL-1) (NN action)))) (VP (MD may) (VP (VB be) (PP (IN of) (NP (JJ therapeutic) (NN value))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (ADJP (ADJP (JJ acute)) (CC or) (ADJP (JJ chronic))) (JJ neuronal) (NN death)))))))))))) (. .)))
